Chronic Pancreatitis Management Strategies

Chronic pancreatitis is a progressive fibro-inflammatory disorder characterised by persistent pain, exocrine and endocrine dysfunction, and an elevated risk of complications such as malnutrition and pancreatic carcinoma. Management strategies centre on a multi-disciplinary approach that integrates lifestyle modification, pharmacotherapy, endoscopic intervention and surgery with ongoing nutritional and psychological support. Initial measures include abstinence from alcohol and tobacco, nutritional optimisation and pancreatic enzyme replacement to address maldigestion. Pain control often requires a step-up strategy from analgesics to neuromodulators, with endoscopic or surgical ductal drainage reserved for refractory pain or ductal obstruction. Recent advances have refined the indications and timing for endoscopic versus surgical intervention, highlighted the importance of early intervention to preserve pancreatic function, and underscored the need for personalised care pathways guided by mechanistic understanding of disease progression. Global efforts now focus on standardising care via evidence-based guidelines, improving quality of life and reducing the burden of exocrine and endocrine insufficiency.

Research from Nature Portfolio

A seminal cohort analysis examined long-term rates and risk factors for steatorrhea in over two thousand patients, revealing that male gender, concomitant diabetes, alcohol abuse and prior pancreaticoduodenectomy significantly increased the risk of fat malabsorption over two decades. Cumulative incidence estimates indicated that by ten years after diagnosis, approximately one in five patients developed steatorrhea, emphasising the need for early identification of high-risk individuals and proactive initiation of enzyme replacement. This work provides a foundation for tailored surveillance and nutritional support to mitigate progressive exocrine insufficiency.

Chronic Pancreatitis Management Strategies publication trend

The graph below shows the total number of articles in chronic pancreatitis management strategies across all publications each year (not limited to Nature Index journals).

Technical terms

Exocrine insufficiency: Inadequate secretion of pancreatic digestive enzymes leading to malabsorption and nutritional deficiencies.

Endocrine insufficiency: Impaired insulin and glucagon secretion by islet cells resulting in dysglycaemia or diabetes.

Pancreatic enzyme replacement therapy (PERT): Oral formulations of lipase, amylase and protease to restore digestive capacity.

Central sensitization: Enhanced responsiveness of central pain pathways due to ongoing nociceptive input, contributing to chronic pain.

Duodenum-preserving pancreatic head resection (DPPHR): Surgical procedure removing inflamed pancreatic tissue while conserving duodenal integrity to relieve pain and preserve function.

Steatorrhea: Passage of excess fat in faeces, often pale and foul-smelling, indicative of severe malabsorption.

References

1. Chronic pancreatitis: review and update of etiology, risk factors, and management. F1000Research (2018).
2. Risk Factors for Steatorrhea in Chronic Pancreatitis: A Cohort of 2,153 Patients. Scientific Reports (2016).
3. International Consensus Guidelines for Risk Factors in Chronic Pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society, and European Pancreatic Club. Pancreatology (2020).
4. Evidence-based clinical practice guidelines for chronic pancreatitis 2021. Journal of Gastroenterology (2022).